BIO-key International (NASDAQ:BKYI – Get Free Report) released its quarterly earnings results on Thursday. The technology company reported ($0.53) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.35) by ($0.18), Zacks reports. BIO-key International had a negative return on equity of 3,124.77% and a negative net margin of 72.53%.
BIO-key International Trading Down 28.8 %
Shares of NASDAQ BKYI traded down $0.32 on Thursday, hitting $0.80. The company’s stock had a trading volume of 585,622 shares, compared to its average volume of 2,220,705. The stock has a 50 day moving average of $1.25 and a 200-day moving average of $1.15. BIO-key International has a 12-month low of $0.52 and a 12-month high of $3.68. The company has a quick ratio of 0.71, a current ratio of 0.78 and a debt-to-equity ratio of 0.63.
BIO-key International Company Profile
Featured Articles
- Five stocks we like better than BIO-key International
- Manufacturing Stocks Investing
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Top 3 Beverage Stocks Pouring Out Profits
- Top Biotech Stocks: Exploring Innovation Opportunities
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.